무석내사생명과학기술주식유한회사

The NEST R&D Center has always been committed to a market-driven innovation strategy. In recent years, NEST has continuously expanded its capabilities in bioprocess consumables, advanced pharmaceutical packaging materials, and precision drug delivery solutions, building a comprehensive one-stop product portfolio that supports scientific research, process development, and industrial-scale manufacturing through continuous innovation. NEST’s R&D strategy and product development are centered around three key principles: Innovation, Compliance, and Continuous Iteration.

I. Bioprocess Consumables

Focusing on applications including cell culture, bioprocess scale-up, and sample management, NEST continues to develop a comprehensive consumables portfolio, including:

10 L / 20 L Square Storage Bottles

5 L High-Efficiency Erlenmeyer Flasks

RFID-Enabled Cryogenic Vials

T400 Cell Culture Flasks

Low-Binding Pipette Tip Series

Enhanced Centrifuge Tubes

General Bioprocess Accessories

NEST continues to improve its end-to-end consumables ecosystem, supporting the entire workflow from laboratory research to biomanufacturing.

2. Advanced Pharmaceutical Packaging Platform

Driven by the needs of emerging therapeutic areas such as GLP-1 therapies, biologics, and cell therapy, NEST develops:

Glass Prefilled Syringe Systems

Cartridge Containers

COP Injection Vials

Vials

Providing innovative drug products with more stable, safe, and compliant packaging solutions.

3. Precision Drug Delivery Solutions

Focusing on chronic disease management and innovative drug delivery requirements, NEST continues to develop:

Pen Injector Assemblies

Automatic Injection Pens

Reusable Injection Devices

Driving the advancement and localization of next-generation drug delivery systems.

II. Key Product Innovations

1. Large-Volume Square Storage Bottles

High transparency and seamless bottle design

High-strength bottle structure

Supports repeated freeze–thaw cycles and autoclaving

Validated through comprehensive testing, including physical performance, biocompatibility, stability, and extractables evaluation, ensuring reliable performance for bioprocess applications.

2. 5 L High-Efficiency Erlenmeyer Flasks

Higher cleanliness

Lower cell shear stress

Enhanced transparency

Improved batch-to-batch consistency

Further improving the stability and reliability of cell culture processes.

3. Low-Binding Pipette Tips

Lower liquid retention

Reduced protein adsorption

Higher pipetting accuracy

Enhanced airtight performance

Helping researchers minimize valuable sample loss and improve experimental reproducibility.

4. RFID-Enabled Cryogenic Vials

Contactless batch identification

Full lifecycle traceability

Automated sample management

Long-term storage at ultra-low temperatures

Advancing biobanks toward digitalized and intelligent sample management.

5. Cartridge Containers

Advanced molding technology – Precision molding with consistent dimensions

Cross-linked siliconization – Formation of a stable polysiloxane coating

Moist heat sterilization – First-of-its-kind application in China

III. GelNest Matrix: Replicating International Standards to Enhance Research Efficiency and Cost Effectiveness

GelNest Matrix adopts a workflow and performance profile aligned with leading international products, enabling researchers to seamlessly transition without changing existing experimental protocols, while offering stable supply and improved cost efficiency.

GelNest Matrix Advantages

① Low Endotoxin Level

Endotoxin level: ≤4 EU/mL

② Stable Protein Concentration

Ensuring consistent gel properties and reliable experimental performance

③ Maintained Bioactivity After Multiple Freeze–Thaw Cycles

Preserving excellent biological activity after repeated freeze–thaw cycles

④ Short-Term Storage at 4°C Supported

From basic research consumables and bioprocess solutions to advanced pharmaceutical packaging and precision drug delivery platforms, NEST R&D Center remains committed to a market-driven innovation strategy, continuously advancing product innovation and technological development.

반환목록

이전：NEST Tube is adopted by WHO, Uganda to test Ebola Vaccines in outbreak 2022-11-24

다음：2026 Top 8 Pen Injector Manufacturers With Yokohama Ties 2026-08-03